20 November 2017
The CORE programme, designed and delivered by PCM Scientific, was awarded ‘Excellence in Collaboration and Partnerships’ at the 2017 Pharmaceutical Market Excellence Awards.
CORE: Hand-in-hand in heart failure
The CORE programme, supported by funding from Novartis Pharma AG, was established to meet the European Society of Cardiology’s call for multidisciplinary programmes to encourage an integrated approach and to reach the expected standards of care for patients with heart failure.
PCM Scientific is a provider of CME programmes that not only reach broad, global audiences but deliver meaningful, measurable and sustainable impact on professional behaviours and patient care.
The team was up against some strong competition, including the British Society of Gastroenterology and Novo Nordisk, but according to the judges there could only be one result: “PCM Scientific’s tailored content approach coupled with their wide-reach scalability proved to be a clear winner. The project is ambitious, well-executed and passion-driven. The simple project management piece really impressed us due to the area’s complexity.”
To find out how to partner with us to build and deliver practice-changing education to your healthcare professional communities, please email Christopher Walsh.
CORE is supported by funding from Novartis Pharma AG. All educational content and materials are created by the CORE Steering Committee in collaboration with PCM Scientific, the medical education company acting as secretariat. The financial supporter has had no involvement in the creation or development of the educational content.